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How do we measure epicardial adipose tissue thickness by 
transthoracic echocardiography?
ABSTRACT
Epicardial adipose tissue (EAT) is a component of the visceral adiposity located between the heart and pericardium. It is associated with cer-
tain diseases, such as metabolic syndrome, coronary artery disease, and hypertension. Therefore, measurement of EAT thickness has recently 
gained importance. Examination by transthoracic echocardiography for measuring EAT thickness is preferable because of easy availability and 
low cost. The present review focuses on the method of measuring EAT thickness by transthoracic echocardiography as well as the issues of 
concern. (Anatol J Cardiol 2015; 15: 416-9)
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Introduction
Epicardial adipose tissue (EAT) is part of visceral adipose 
tissue localized between the heart and pericardium, particularly 
in the atrioventricular and interventricular sulcus, lateral wall of 
the right ventricle, and around the coronary arteries (1-3). EAT 
has endocrine, paracrine, vasocrine, and inflammatory charac-
teristics (4-6) and is associated with metabolic syndrome (7), 
insulin resistance (8), coronary artery disease (9, 10), and hyper-
tension (11, 12). Therefore, measurement of EAT thickness has 
gained importance. EAT thickness can be measured by transtho-
racic echocardiography, cardiac computed tomography (CT), 
and cardiac magnetic resonance imaging (MRI) methods. 
Evaluation by transthoracic echocardiography has come to the 
forefront because of many advantages, such as easy availability, 
low cost, no radiation exposure, fastness, and reproducibility. 
Measurement of EAT thickness by transthoracic echocardiogra-
phy is discussed in this article.
EAT measurement by echocardiography was first defined in 
2003 by Iacobellis et al. (13). They expressed EAT as an echo-
free space above the right ventricular free wall by transthoracic 
echocardiography and measured the thickness from the anterior 
aspect of the right ventricular free wall through parasternal long 
and short axis windows (13). They stated that the reason for 
them to prefer this point was the highest EAT thickness in that 
area and optimal cursor beam orientation in each view (13). By 
this method, they determined that EAT measurements are cor-
related with MRI measurements and confirmed the accuracy of 
measurements by echocardiography (13). Further studies began 
to measure EAT thickness considering this method, which was 
recommended by Iacobellis et al. (13), as the reference.
How is the epicardial adipose tissue measured and from 
where?
EAT demonstrated by transthoracic echocardiography is the 
echo-lucent area between the epicardium of the right ventricle 
and parietal pericardium, which is seen as a thick line above the 
right ventricular free wall on echo (Fig. 1, 2) (7, 9).
For EAT measurement, the individual is placed in the left 
lateral decubitus position, and an optimal parasternal long-axis 
view is tried to be obtained through the left sternal 2-3 intercos-
tal space. Interventricular septum and particularly the aortic 
root are considered as the reference points for the measure-
ment from the parasternal long-axis view. Taking the aortic root 
as the reference, measurement is made by putting the right 
ventricular free wall and the aortic annulus in the midline of 
ultrasound waves (Fig. 3) (14-18). The hypoechoic area extend-
ing from epicardial surface to the parietal pericardium in front of 
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the right ventricular free wall is vertically measured at the thick-
est level (Fig. 3). More sensitive measurements can be made by 
enhancing depth setting and magnifying the view to assess EAT 
thickness more clearly (Fig. 4) (9). Some references recommend 
the measurements to be made in three (3, 15, 17, 18), some refer-
ences recommend to be made in six (9), and some references 
recommend to be made in 10 (3) cardiac cycles. Making the 
measurements in at least three cardiac cycles, calculating the 
mean value, and not being satisfied with a single measurement 
would be convenient for accurate measurement.
After measuring from the parasternal long-axis, the probe is 
switched to 90° clockwise and parasternal short-axis view is 
obtained. In the parasternal short-axis view, mid-chordal region 
(19), the tip of the papillary muscles (18, 19), and interventricular 
septum (19) can be regarded as reference points (19). In general, 
measurement from 2 cm away from the interventricular septum 
(14, 16) and from the parasternal short-axis mid-ventricular level 
is recommended (20). EAT is measured from the echo-lucent 
area between the right ventricle and parietal pericardium on the 
parasternal short axis section as shown in Figure 5 (3). 
Parasternal long- and short-axis measurements must be aver-
aged to obtain the mean thickness.
In the initial publications, although EAT was most frequently 
measured during end-systole due to deformation and pressure 
on EAT in the distal aspect (13, 14), it is measured, in some pub-
lications during end-diastole in order to be consistent with car-
diac CT and MRI (9, 15, 19). In our studies, we prefer measuring 
EAT thickness during diastole (10, 11, 16). Performing EAT mea-
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Figure 1. Transthoracic echocardiographic view of epicardial adipose 
tissue. Epicardial adipose tissue is an echo-lucent area between 
epicardial surface and parietal pericardium in front of the right 
ventricular free wall and is pointed by a white arrow
Ao- aorta; EAT- epicardial adipose tissue; IVS- interventricular septum; LA- left atrium; LV- 
left ventricle; RV- right ventricle
Figure 3. Making measurement by taking the aortic root as the reference 
and placing in the midline between the right ventricular free wall and 
aortic annulus. Vertical length between the right ventricular free wall 
and parietal pericardium is measured. The area between the white 
arrows indicates epicardial adipose tissue thickness
Ao- aorta; EAT- epicardial adipose tissue; RV- right ventricle
Figure 2. The view of epicardial adipose tissue(zoomed in). Epicardial 
adipose tissue is an echo-lucent area between the epicardium of the 
right ventricle and parietal pericardium in front of the right ventricular 
free wall
EAT- epicardial adipose tissue; RV- right ventricle
Figure 4. The borders of epicardial adipose tissue in magnified size 
and measurement of epicardial adipose tissue. White arrow points out 
the measurement of epicardial adipose tissue thickness
surement during end-diastole just before the R-wave on the ECG 
would be convenient for the standardization of publications and 
measurements (3). It should be kept in mind that end-systolic 
measurements will reveal higher values as compared with end-
diastolic measurements. Therefore, it is necessary to pay atten-
tion whether measurements have been made during end-systole 
or -diastole while interpreting EAT thickness in the publications.
How can we differentiate epicardial adipose tissue from 
pericardial adipose tissue?
One of the important issues to pay attention while measuring 
EAT thickness is to make a clear differentiation between peri-
cardial adipose tissue and EAT. Pericardial adipose tissue and 
EAT arise from different embryonic origins; their local circulation 
and biomolecular features are different (21). EAT should be dif-
ferentiated from pericardial adipose tissue because it is a real 
visceral adipose tissue (21). 
Pericardial adipose tissue is the hypoechoic area in front of 
EAT and parietal pericardium (Fig. 6) (19). Although different 
from EAT, it does not alter with cardiac cycle (19, 21). It can be 
easily differentiated from EAT with these features. 
Differentiation between epicardial adipose tissue and peri-
cardial effusion
Differentiating EAT from pericardial effusion is of great 
importance. Even though the EAT is viewed as a hypoechoic 
area, it has different features from pericardial effusion. EAT has 
specific echo-density that comprises echo-lucent areas and 
whitish-speckled appearance (16). However, pericardial effusion 
has more hypoechoic appearance. In addition, although EAT is 
limited to the front of the right ventricle, pericardial effusion 
reveals wider spread, and usually it is more prominent in the 
posterolateral aspect of the left ventricle while the patient is left 
lateral decubitis position.
What is the normal value of epicardial adipose tissue 
thickness?
There is yet no definite value considered normal for EAT 
thickness. There are inconsistencies in the literature regarding 
EAT thickness. Iacobellis et al. (13) found that EAT thickness 
measured during end-systole to be minimum 1 mm and maximum 
22.6 mm with a mean value of 7 mm in males and 6.5 mm in 
females among individuals evaluated by echocardiography for 
standard clinical indications (19). When measured in end-dias-
tole, Jeong et al. (15) found a mean value of 6.38 mm (1.1-16.6 
mm) in 203 individuals referred to coronary angiography, and 
Nelson et al. (22) found a mean of 4.7±1.5 mm in 356 asymptom-
atic patients. Mookadam et al. (23) stated that an EAT thickness 
>5 mm during end-diastole is associated with cardiac abnor-
malities (left atrial dilatation, lower ejection fraction, increased 
left ventricular mass, and diastolic dysfunction) that have been 
detected by echocardiography. In another study, 7.6 mm and 
higher values measured during end-diastole (15) and in our pre-
vious study, 5.2 mm and higher values measured in end-diastole 
(10) were found as threshold limit values associated with the 
presence of coronary artery disease. Likewise, threshold limit 
values for subclinical atherosclerosis (24), metabolic syndrome 
(19), low coronary flow reserve (16), and hypertension (11) have 
also been defined. Bertaso et al. (3) suggested that in system-
atic review measurements >5 mm should represent a relevant 
cutoff to define increased EAT thickness, particularly in low-risk 
populations. Possibly measurements >5 mm during end-diastole 
could be a cut-off value increased epicardial fat, but that value 
should be supported by a large studies.
While interpreting these threshold limit values, it should be 
kept in mind that EAT thickness could be influenced by age, gen-
der, and race and whether the measurement was done during 
end-systole or -diastole.
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Figure 5. Measurement of epicardial adipose tissue thickness from 
parasternal short axis view. Epicardial adipose tissue thickness is 
marked by white two-sided arrow
EAT - epicardial adipose tissue; LV - left ventricle; RV - right ventricle
Figure 6. Differentiation between epicardial adipose tissue and 
pericardial adipose tissue. Epicardial adipose tissue is pointed out by 
white arrow, and pericardial adipose tissue is pointed out by dashed-
line arrow
EAT - epicardial adipose tissue; PAT- pericardial adipose tissue
Limitations to measuring epicardial adipose tissue thickness 
by transthoracic echocardiography
There are several limitations to the measurement of EAT 
thickness by transthoracic echocardiography. First, we only par-
tially measure EAT by transthoracic echocardiography. In con-
trast, both EAT thickness and volume can be measured by car-
diac CT and MRI precisely and more accurately than echocar-
diography. Echocardiographic measurements are not as repro-
ducible as cardiac CT and MRI. Another limitation is the rela-
tively poor inter-observer and intra-observer variability as com-
pared with cardiac MRI and CT. The foremost limitation is the 
lack of certain threshold values to predict in pathologies. EAT 
thickness appears to increase with age, and it could be influ-
enced with gender and ethnicity. Although EAT measurement by 
echocardiography has some limitations, it has the advantage of 
being an easy, readily available, repeatable, and low cost modal-
ity without radiation exposure.
Conclusion
EAT, which still remains a mystery despite new information 
determined with each passing day, can be easily, cost affec-
tively, and reproducibly evaluated by transthoracic echocardiog-
raphy. EAT assessment is still a subject of research; however, it 
appears to be an additional promising marker in assessing car-
diovascular and metabolic risks in daily clinical practice.
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